7-Minute Lung Cancer Immunotherapy Introduced in India
A new under-the-skin immunotherapy treatment for lung cancer, Tecentriq (atezolizumab), has been launched in India, offering a much faster alternative…
A new under-the-skin immunotherapy treatment for lung cancer, Tecentriq (atezolizumab), has been launched in India, offering a much faster alternative…
The Centre has introduced revised recruitment rules for the Drugs Controller General of India (DCGI), aiming to fix long-standing issues…
In line with a recent judgment by the Supreme Court of India, the National Medical Commission (NMC) has directed all…
In a recent drug safety update, 60 batches of medicines and medical devices have been classified as Not of Standard…
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…
Novartis AG’s move to exit its small Indian subsidiary once again highlights the limited appetite of global pharmaceutical giants to…
India is facing a rising incidence of metabolic, degenerative and autoimmune disorders, largely due to changing lifestyles and increasing environmental…
The detection of a counterfeit batch of Abhayrab, a rabies vaccine manufactured by government-owned Indian Immunologicals Limited (IIL), has highlighted…
AIIMS Delhi has conducted India’s first dedicated clinical trial of an advanced brain stent for the treatment of severe strokes,…
The Central Drugs Standard Control Organisation (CDSCO) has initiated a 100-day nationwide awareness campaign highlighting the recent reduction in Goods…